2-Apr-2026
Most and least shorted mid-to mega-cap healthcare stocks in March
Seeking Alpha News (Fri, 3-Apr 8:00 AM ET)
Acadia Healthcare Appoints Daniel Cancelmi to Board of Directors
Business Wire (Thu, 12-Mar 4:15 PM ET)
Market Chameleon (Wed, 25-Feb 6:14 AM ET)
Volume Growth Drives Acadia's Record Revenue in Q4 2025 as Leadership Shifts with New CEO
Market Chameleon (Wed, 25-Feb 2:54 AM ET)
Acadia Healthcare Announces Fourth Quarter and 2025 Results
Business Wire (Wed, 25-Feb 7:00 AM ET)
Acadia Healthcare to Participate in March Investor Conferences
Business Wire (Fri, 20-Feb 11:00 AM ET)
Business Wire (Fri, 6-Feb 8:00 AM ET)
Acadia Healthcare Announces Date for Fourth Quarter and Year-End 2025 Earnings Release
Business Wire (Wed, 4-Feb 10:00 AM ET)
Acadia Healthcare Reaffirms 2025 Outlook as Debbie Osteen Returns to Lead Company
Market Chameleon (Tue, 20-Jan 3:54 AM ET)
Acadia Healthcare Appoints Debbie Osteen as Chief Executive Officer
Business Wire (Tue, 20-Jan 8:00 AM ET)
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Its facilities and services are classified into the following categories: acute inpatient psychiatric facilities; specialty treatment facilities; CTCs; and residential treatment centers. In which Acute inpatient psychiatric facilities contribute the majority of revenue in the United States. The Company has one reportable segment, behavioral healthcare services. The behavioral healthcare services segment provides inpatient and outpatient behavioral healthcare services.
Acadia Healthcare Company trades on the NASDAQ stock market under the symbol ACHC.
As of April 2, 2026, ACHC stock price climbed to $23.96 with 1,997,386 million shares trading.
ACHC has a beta of 0.64, meaning it tends to be less sensitive to market movements. ACHC has a correlation of 0.02 to the broad based SPY ETF.
ACHC has a market cap of $2.21 billion. This is considered a Mid Cap stock.
Last quarter Acadia Healthcare Company reported $821 million in Revenue and $.07 earnings per share. This beat revenue expectation by $22 million and exceeded earnings estimates by $.03.
In the last 3 years, ACHC traded as high as $87.77 and as low as $11.43.
The top ETF exchange traded funds that ACHC belongs to (by Net Assets): IJR, VTI, VB, FXH, VBR.
ACHC has underperformed the market in the last year with a return of -19.9%, while SPY returned +18.2%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in ACHC shares. However, ACHC has outperformed the market in the last 3 month and 2 week periods, returning +68.9% and +3.3%, while SPY returned -3.6% and -0.6%, respectively. This indicates ACHC has been having a stronger performance recently.
ACHC support price is $22.88 and resistance is $24.46 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ACHC shares will trade within this expected range on the day.